Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Google News
openpr.com > news > 4628199 > mantle-cell-lymphoma-pipeline-2026-moa-roa-fda-approved

Mantle Cell Lymphoma Pipeline 2026: MOA, ROA, FDA-Approved

3+ day, 15+ hour ago   (62+ words) openPR.com Mantle Cell Lymphoma Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight Press release from: DelveInsight Business Research Permanent link to this press release: You can edit or delete your press release Mantle Cell Lymphoma…...

openPR.com
openpr.com > news > 4627212 > the-proteolysis-targeting-chimera-protac-protein-degrader

The PROteolysis TArgeting Chimera (PROTAC) Protein Degrader Cancer Therapeutics Market is projected to grow to $4.25 billion by 2030, fueled by increasing industry demand.

4+ day, 2+ hour ago   (88+ words) The PROteolysis TArgeting Chimera (PROTAC) Protein Degrader openPR.com The PROteolysis TArgeting Chimera (PROTAC) Protein Degrader Cancer Therapeutics Market is projected to grow to $4.25 billion by 2030, fueled by increasing industry demand. Press release from: The Business Research Company PROteolysis TArgeting…...

openPR.com
openpr.com > news > 4626844 > new-scottsdale-back-pain-clinic-guide-from-daily-news-plus

New Scottsdale Back Pain Clinic Guide from Daily News Plus Evaluates Nine Providers for 2026

4+ day, 9+ hour ago   (67+ words) openPR.com New Scottsdale Back Pain Clinic Guide from Daily News Plus Evaluates Nine Providers for 2026 Press release from: Daily News Plus Permanent link to this press release: You can edit or delete your press release New Scottsdale Back Pain…...

openPR.com
openpr.com > news > 4626566 > rna-therapeutics-market-is-going-to-boom-moderna

RNA Therapeutics Market Is Going to Boom |• Moderna • BioNTech • CureVac

4+ day, 20+ hour ago   (50+ words) openPR.com RNA Therapeutics Market Is Going to Boom |• Moderna • BioNTech • CureVac Press release from: WMR Permanent link to this press release: You can edit or delete your press release RNA Therapeutics Market Is Going to Boom |• Moderna • BioNTech • CureVac…...

openPR.com
openpr.com > news > 4626361 > esthetica-medical-furniture-gives-indian-hospitals-a-better-way

Esthetica Medical Furniture Gives Indian Hospitals a Better Way to Buy Clinical Seating and Tables

4+ day, 22+ hour ago   (67+ words) openPR.com Esthetica Medical Furniture Gives Indian Hospitals a Better Way to Buy Clinical Seating and Tables Press release from: Esthetica Medical Furniture Permanent link to this press release: You can edit or delete your press release Esthetica Medical Furniture…...

openPR.com
openpr.com > news > 4624992 > parp-inhibitors-clinical-trial-pipeline-gains-momentum-20

PARP Inhibitors Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

5+ day, 22+ hour ago   (65+ words) PARP Inhibitors Clinical Trial Pipeline Gains Momentum: 20+ openPR.com PARP Inhibitors Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight Press release from: DelveInsight Business Research LLP Permanent link to this press release: You can…...

openPR.com
openpr.com > news > 4624949 > tigit-inhibitors-clinical-trial-pipeline-gains-momentum-14

TIGIT Inhibitors Clinical Trial Pipeline Gains Momentum: 14+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

5+ day, 23+ hour ago   (65+ words) TIGIT Inhibitors Clinical Trial Pipeline Gains Momentum: 14+ openPR.com TIGIT Inhibitors Clinical Trial Pipeline Gains Momentum: 14+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight Press release from: DelveInsight Business Research LLP Permanent link to this press release: You can…...

openPR.com
openpr.com > news > 4624159 > osteoarthritis-clinical-trial-pipeline-appears-robust-with

Osteoarthritis Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

6+ day, 16+ hour ago   (63+ words) Osteoarthritis Clinical Trial Pipeline Appears Robust With openPR.com Osteoarthritis Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight Press release from: ABNewswire Permanent link to this press release: You can edit or…...

openPR.com
openpr.com > news > 4623236 > medical-scar-patches-market-is-going-to-boom-mederma-nexcare

Medical Scar Patches Market Is Going to Boom | Mederma, Nexcare, BioCorneum

1+ week, 5+ hour ago   (55+ words) openPR.com Medical Scar Patches Market Is Going to Boom | Mederma, Nexcare, BioCorneum Press release from: Coherent Market Insights Permanent link to this press release: You can edit or delete your press release Medical Scar Patches Market Is Going to…...

openPR.com
openpr.com > news > 4623102 > diabetic-macular-edema-clinical-trial-pipeline-analysis-45

Diabetic Macular Edema Clinical Trial Pipeline Analysis: 45+ Key Companies Shaping the Future of Diabetic Macular Edema Therapeutics | DelveInsight

1+ week, 18+ hour ago   (69+ words) Diabetic Macular Edema Clinical Trial Pipeline Analysis: 45+ openPR.com Diabetic Macular Edema Clinical Trial Pipeline Analysis: 45+ Key Companies Shaping the Future of Diabetic Macular Edema Therapeutics | DelveInsight Press release from: DelveInsight Business Research LLP Permanent link to this press release:…...